Efficacy of non-vitamin K antagonist oral anticoagulants for Lemierre syndrome

Am J Emerg Med. 2016 Oct;34(10):2059.e3-2059.e5. doi: 10.1016/j.ajem.2016.03.040. Epub 2016 Mar 18.

Authors

Masayuki Kubota¹, Hiroaki Daidoji², Nobuhiro Takaya², Kurato Tokunaga², Tomohiro Sonoo³, Kensuke Nakamura²

Affiliations

¹ Hitachi General Hospital, Emergency and Critical Care Medicine Department, 2-1-1, Zyonan-cho, Hitachi-shi, Ibaraki, Japan, 3170077. Electronic address: [email protected].
² Hitachi General Hospital, Emergency and Critical Care Medicine Department, 2-1-1, Zyonan-cho, Hitachi-shi, Ibaraki, Japan, 3170077.
³ The University of Tokyo Hospital, Emergency and Critical Care Medicine Department, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan, 1138655.

PMID: 27079502
DOI: 10.1016/j.ajem.2016.03.040

No abstract available

Publication types

Case Reports

MeSH terms

Administration, Oral
Ampicillin / therapeutic use
Anti-Bacterial Agents / therapeutic use
Anticoagulants / therapeutic use*
Bacteremia / complications
Bacteremia / drug therapy
Factor Xa Inhibitors / therapeutic use
Female
Heparin / therapeutic use*
Humans
Lemierre Syndrome / complications
Lemierre Syndrome / drug therapy*
Middle Aged
Pyridines / therapeutic use*
Streptococcal Infections / complications
Streptococcal Infections / drug therapy
Streptococcus pyogenes
Sulbactam / therapeutic use
Thiazoles / therapeutic use*

Substances

Anti-Bacterial Agents
Anticoagulants
Factor Xa Inhibitors
Pyridines
Thiazoles
sultamicillin
Ampicillin
Heparin
edoxaban
Sulbactam